VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
8934
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1251
Interactions with Platform & by Email
PARTICIPANTS
268
Unique # Participated
VALIDATIONS
121
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
126
PAGES
199
EDITION
9
PRICE
USD $4950
Is the U.S. Still a Better Global Barometer than China?
Amid the COVID-19 crisis, the global market for Protein Therapeutics estimated at US$164.2 Billion in the year 2020, is projected to reach a revised size of US$233.1 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$122.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Insulin segment is readjusted to a revised 5.4% CAGR for the next 7-year period.
The Protein Therapeutics market in the U.S. is estimated at US$48.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$41 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
In the global Fusion Protein segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$15 Billion in the year 2020 will reach a projected size of US$20.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$26.7 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 199-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories; Amgen, Inc.; AstraZeneca PLC; Baxter International, Inc.; Biogen, Inc.; Boehringer Ingelheim International GmbH; Chugai Pharmaceutical Co., Ltd.; Diasome Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; Genentech, Inc.; Generex Biotechnology Corporation; GeneScience Pharmaceuticals Co., Ltd.; Hualan Biological Engineering, Inc.; Johnson & Johnson; Kyowa Hakko Kirin Co., Ltd.; Merck Serono SA; Novo Nordisk A/S; Oramed Pharmaceuticals Inc.; Sandoz International GmbH; Teva Pharmaceutical Industries Ltd.
» Application (Metabolic Disorders, Immunological Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) » Product Type (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Other Product Types)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Protein Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Protein Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Protein Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Protein Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Metabolic Disorders (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Metabolic Disorders (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Metabolic Disorders (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Immunological Disorders (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 |
| Immunological Disorders (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 |
| Immunological Disorders (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| Hematological Disorders (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Hematological Disorders (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Hematological Disorders (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Cancer (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Cancer (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Cancer (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Hormonal Disorders (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Hormonal Disorders (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Hormonal Disorders (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Genetic Disorders (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Genetic Disorders (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Genetic Disorders (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Monoclonal Antibodies (Product Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Monoclonal Antibodies (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Monoclonal Antibodies (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Insulin (Product Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Insulin (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Insulin (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Fusion Protein (Product Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Fusion Protein (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Fusion Protein (Product Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Erythropoietin (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Erythropoietin (Product Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Erythropoietin (Product Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Interferon (Product Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Interferon (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Interferon (Product Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Product Types (Product Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 |
| Other Product Types (Product Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Other Product Types (Product Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Protein Therapeutics Market Share (in %) by Company: 2019 & 2025 |
| United States Protein Therapeutics Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Protein Therapeutics Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Protein Therapeutics Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| United States Protein Therapeutics Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025 |
| Protein Therapeutics Market in the United States by Product Type: A Historic Review in US$ Million for 2009-2017 |
| United States Protein Therapeutics Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Protein Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Protein Therapeutics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Protein Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Canadian Protein Therapeutics Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Canadian Protein Therapeutics Historic Market Review by Product Type in US$ Million: 2009-2017 |
| Protein Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Demand Estimates and Forecasts for Protein Therapeutics in US$ Million by Application: 2018 to 2025 |
| Japanese Protein Therapeutics Market in US$ Million by Application: 2009-2017 |
| Protein Therapeutics Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| Japanese Market for Protein Therapeutics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Protein Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017 |
| Japanese Protein Therapeutics Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Demand for Protein Therapeutics in US$ Million by Application: 2018 to 2025 |
| Protein Therapeutics Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Protein Therapeutics Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Chinese Protein Therapeutics Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Protein Therapeutics Historic Market Analysis in China in US$ Million by Product Type: 2009-2017 |
| Chinese Protein Therapeutics Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Protein Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Protein Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Protein Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Protein Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Protein Therapeutics Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Protein Therapeutics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Protein Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| European Protein Therapeutics Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Protein Therapeutics Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2009-2017 |
| European Protein Therapeutics Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| FRANCE |
| Protein Therapeutics Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Protein Therapeutics Historic Market Review in US$ Million by Application: 2009-2017 |
| French Protein Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Protein Therapeutics Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Protein Therapeutics Historic Market Scenario in US$ Million by Product Type: 2009-2017 |
| French Protein Therapeutics Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| GERMANY |
| Protein Therapeutics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Protein Therapeutics Market in Retrospect in US$ Million by Application: 2009-2017 |
| Protein Therapeutics Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Protein Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| German Protein Therapeutics Historic Market Analysis in US$ Million by Product Type: 2009-2017 |
| German Protein Therapeutics Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Demand for Protein Therapeutics in US$ Million by Application: 2018 to 2025 |
| Protein Therapeutics Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Protein Therapeutics Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Italian Protein Therapeutics Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Protein Therapeutics Historic Market Analysis in Italy in US$ Million by Product Type: 2009-2017 |
| Italian Protein Therapeutics Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Demand Estimates and Forecasts for Protein Therapeutics in US$ Million by Application: 2018 to 2025 |
| United Kingdom Protein Therapeutics Market in US$ Million by Application: 2009-2017 |
| Protein Therapeutics Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Protein Therapeutics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Protein Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017 |
| United Kingdom Protein Therapeutics Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Protein Therapeutics Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Protein Therapeutics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Protein Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe Protein Therapeutics Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Protein Therapeutics Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Protein Therapeutics Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Protein Therapeutics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Protein Therapeutics Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Protein Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Protein Therapeutics Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Protein Therapeutics Historic Market Scenario in US$ Million by Product Type: 2009-2017 |
| Asia-Pacific Protein Therapeutics Market Share Analysis by Product Type: 2009 VS 2019 VS 2025 |
| REST OF WORLD |
| Rest of World Protein Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Protein Therapeutics Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Rest of World Protein Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of World Protein Therapeutics Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Rest of World Protein Therapeutics Historic Market Review by Product Type in US$ Million: 2009-2017 |
| Protein Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 43 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com